According to a new report from Intel Market Research, the North America Personalized mRNA Cancer Vaccine Therapy Market was valued at USD 0.86 billion in 2024 and is projected to grow from USD 0.92 billion in 2025 to USD 1.30 billion by 2032, exhibiting a robust CAGR of approximately 7.5% during the forecast period. Market growth is driven by increasing cancer prevalence, advancements in mRNA...